| EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update C Dejaco, S Ramiro, M Bond, P Bosch, C Ponte, SL Mackie, TA Bley, ... Annals of the rheumatic diseases 83 (6), 741-751, 2024 | 207 | 2024 |
| Management of Behcet’s syndrome O Karadag, EC Bolek Rheumatology 59 (Supplement_3), iii108-iii117, 2020 | 80 | 2020 |
| Do ANCA‐associated vasculitides and IgG4‐related disease really overlap or not? A Erden, EC Bolek, KG Yardimci, L Kilic, SA Bilgen, O Karadag International Journal of Rheumatic Diseases 22 (10), 1926-1932, 2019 | 36 | 2019 |
| Is Takayasu’s arteritis more severe in children EC Bolek, U Kaya Akca, A Sari, E Sag, S Demir, L Kilic, YZ Sener, ... Clin Exp Rheumatol 39 (Suppl 129), 32-8, 2021 | 33 | 2021 |
| Somatic mutations in rheumatological diseases: VEXAS syndrome and beyond KA Sikora, KV Wells, EC Bolek, AI Jones, PC Grayson Rheumatology 61 (8), 3149-3160, 2022 | 31 | 2022 |
| COVID-19 among patients with inflammatory rheumatic diseases SN Esatoglu, K Tascilar, H Babaoğlu, C Bes, B Yurttas, S Akar, ... Frontiers in immunology 12, 651715, 2021 | 29 | 2021 |
| Clinical features and disease course of neurological involvement in Behcet's disease: HUVAC experience EC Bolek, A Sari, L Kilic, U Kalyoncu, A Kurne, KK Oguz, MA Topcuoglu, ... Multiple sclerosis and related disorders 38, 101512, 2020 | 29 | 2020 |
| Emergence of colistin and carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CCR-Acb) complex in a neurological intensive care unit followed by … G Metan, P Zarakolu, B Otlu, I Tekin, H Aytac, EÇ Bölek, BC Metin, ... Journal of infection and public health 13 (4), 564-570, 2020 | 24 | 2020 |
| Efficacy, retention, and safety of tofacitinib in real-life: Hur-bio monocentric experience E Bilgin, F Ceylan, E Duran, B Farisoğullari, EÇ Bölek, GK Yardimci, ... Turkish Journal of Medical Sciences 51 (1), 297-308, 2021 | 21 | 2021 |
| Rare occupational cause of nasal septum perforation: Nickel exposure E BÖLEK, A Erden, M KÜLEKÇİ, U Kalyoncu, Ö KARADAĞ International journal of occupational medicine and environmental health 30 (6), 2017 | 16 | 2017 |
| A prospective observational cohort study and systematic review of 40 patients with mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome Y Luo, EC Bolek, KA Quinn, K Wells, E Rose, K Sikora, W Goodspeed, ... Seminars in Arthritis and Rheumatism 52, 151924, 2022 | 15 | 2022 |
| Use of 18F-fluorodeoxyglucose positron emission tomography to standardize clinical trial recruitment in Takayasu’s arteritis KA Quinn, HD Alessi, C Ponte, E Rose, MA Ahlman, C Redmond, Y Luo, ... Rheumatology 61 (10), 4047-4055, 2022 | 14 | 2022 |
| Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International Study O Karadag, EC Bolek, G Ayan, AJ Mohammad, PC Grayson, C Pagnoux, ... Arthritis & Rheumatology, 2024 | 12 | 2024 |
| Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis B Armağan, L Kılıç, B Farisoğulları, GK Yardımcı, E Bilgin, EÇ Bölek, ... Rheumatology International 43 (1), 147-156, 2023 | 12 | 2023 |
| Cancer incidence in Behçet’s disease DC Guven, EC Bolek, SE Altintop, B Celikten, BY Aktas, S Kiraz, İ Gullu, ... Irish Journal of Medical Science (1971-) 189, 1209-1214, 2020 | 12 | 2020 |
| The clinical features and outcomes of Turkish patients with IgG4-related disease: a single-center experience Ö Karadağ, A Erden, EA Ayhan, EÇ BÖLEK, U Kalyoncu, B Armağan, ... Turkish journal of medical sciences 47 (5), 1307-1314, 2017 | 12 | 2017 |
| Coronary (peri)‐arteritis in patients with IgG4‐related disease: A case series from the Central Anatolia Region of Turkey GK Yardimci, S Ardali Duzgun, EC Bolek, L Kilic, U Canpolat, T Hazirolan, ... International Journal of Rheumatic Diseases 24 (8), 1004-1013, 2021 | 11 | 2021 |
| Direct oral anticoagulant for venous thrombosis in Behçet's syndrome M Vautier, Y Gallien, G Emmi, A Bettiol, O Karadag, EC Bolek, D Prisco, ... Autoimmunity reviews 20 (4), 102783, 2021 | 10 | 2021 |
| Interferon alpha might be an alternative therapeutic choice for refractory Neuro-Behçet's disease EC Bolek, A Sari, L Kilic, O Karadag Multiple sclerosis and related disorders 29, 153, 2019 | 10 | 2019 |
| Successful Treatment of Amyloid A–Type Amyloidosis Due to Behçet Disease With Tocilizumab A Ilbay, A Erden, A Sari, B Armagan, BY Aktas, EC Bolek, U Kalyoncu, ... JCR: Journal of Clinical Rheumatology 25 (4), e43-e45, 2019 | 9 | 2019 |
